Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pecci

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Orphanet Journal of Rare Diseases|July 2, 2014
Cochlear implantation is safe and effective in patients with MYH9-related diseaseAlessandro Pecci, Eva J J Verver, Nicole Schlegel, et al.
Hamostaseologie|July 12, 2018
MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the DisorderCarlo Zaninetti, Daniela De Rocco, Tania Giangregorio, et al.
Thrombosis and Haemostasis|January 16, 2016
SLFN14-related thrombocytopenia: identification within a large series of patients with inherited thrombocytopeniaCaterina Marconi, Christian A Di Buduo, Serena Barozzi, et al.
Blood|November 30, 2011
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicityKeri B Sanborn, Emily M Mace, Gregory D Rak, et al.
Blood|September 23, 2008
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patientsAugusto B Federici, Pier M Mannucci, Giancarlo Castaman, et al.
Biochimica Et Biophysica Acta|December 12, 2013
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergeticsDaniela De Rocco, Cristina Cerqua, Paola Goffrini, et al.
Platelets|October 29, 2009
MYH9 related disease: a novel missense Ala95Asp mutation of the MYH9 geneDaniela de Rocco, Paula G Heller, Giorgia Girotto, et al.
Journal of Hematology & Oncology|January 20, 2017
5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemiaCaterina Marconi, Ilaria Canobbio, Valeria Bozzi, et al.
Haematologica|January 21, 2021
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel <i>GFI1B</i> germline mutationMichela Faleschini, Nicole Papa, Marie-Christine Morel-Kopp, et al.
Anaerobe|August 18, 2023
Common laboratory tests and their correlation with the clinical presentation and prognosis of Lemierre syndromeRiccardo M Fumagalli, Elvira Gloor, Philippe A Kaufmann, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Orphanet Journal of Rare Diseases|July 2, 2014
Cochlear implantation is safe and effective in patients with MYH9-related diseaseAlessandro Pecci, Eva J J Verver, Nicole Schlegel, et al.
Hamostaseologie|July 12, 2018
MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the DisorderCarlo Zaninetti, Daniela De Rocco, Tania Giangregorio, et al.
Thrombosis and Haemostasis|January 16, 2016
SLFN14-related thrombocytopenia: identification within a large series of patients with inherited thrombocytopeniaCaterina Marconi, Christian A Di Buduo, Serena Barozzi, et al.
Blood|November 30, 2011
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicityKeri B Sanborn, Emily M Mace, Gregory D Rak, et al.
Blood|September 23, 2008
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patientsAugusto B Federici, Pier M Mannucci, Giancarlo Castaman, et al.
Biochimica Et Biophysica Acta|December 12, 2013
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergeticsDaniela De Rocco, Cristina Cerqua, Paola Goffrini, et al.
Platelets|October 29, 2009
MYH9 related disease: a novel missense Ala95Asp mutation of the MYH9 geneDaniela de Rocco, Paula G Heller, Giorgia Girotto, et al.
Journal of Hematology & Oncology|January 20, 2017
5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemiaCaterina Marconi, Ilaria Canobbio, Valeria Bozzi, et al.
Haematologica|January 21, 2021
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel <i>GFI1B</i> germline mutationMichela Faleschini, Nicole Papa, Marie-Christine Morel-Kopp, et al.
Anaerobe|August 18, 2023
Common laboratory tests and their correlation with the clinical presentation and prognosis of Lemierre syndromeRiccardo M Fumagalli, Elvira Gloor, Philippe A Kaufmann, et al.
Pageof 13